AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Industry:
Vaccine/Drug
Number Of Exists:
N/A
Headquarters:
Denmark
Investment Stage:
N/A
Funding Status:
N/A
Employee Number:
N/A
Technology:
COVID
Founded Date:
N/A
Investor Type:
N/A